BioRestorative Therapies (BRTX) Short Interest Ratio & Short Volume

Short interest is the volume of BioRestorative Therapies shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 172,700 shares of BRTX short. 3.18% of BioRestorative Therapies' shares are currently sold short. Learn More on BioRestorative Therapies' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.18% of BioRestorative Therapies' floating shares are currently sold short.

BioRestorative Therapies saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 172,700 shares, a decrease of 16.8% from the previous total of 207,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

BioRestorative Therapies currently has issued a total of 7,505,000 shares. Some of BioRestorative Therapies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioRestorative Therapies currently has a public float of 5,430,000 shares.

3.18% of BioRestorative Therapies' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to BioRestorative Therapies: Concord Medical Services Holdings Limited (1.76%), Burning Rock Biotech Limited (0.44%), Enzo Biochem, Inc. (0.97%), Mangoceuticals, Inc. (9.16%), Ontrak, Inc. (0.53%), BioNexus Gene Lab Corp. (4.36%), Aclarion, Inc. (10.15%), Vsee Health, Inc. (0.53%), ATI Physical Therapy, Inc. (5.31%), NewGenIvf Group Limited (0.73%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

Short selling BRTX is an investing strategy that aims to generate trading profit from BioRestorative Therapies as its price is falling. BRTX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BioRestorative Therapies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BRTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BRTX, twice per month. The most recent reporting period available is April, 30 2025.